Sidley represented Cellomics on the financing. Cellomics announced its Series B+ financing. The lead investor is an equity fund of a Hong Kong-listed insurance company. The...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
